The invention discloses a targeted
drug liposome for inhibiting pulmonary vascular endothelial
cell glycocalyx abscission and improving a microenvironment before tumor
metastasis, which consists of a
glycocalyx abscission enzyme inhibitor, a lipid material and an adhesion
receptor dipeptidase-1
binding peptide, the lipid material comprises a
phosphatidyl ethanolamine derivative, a long-circulating lipid material, a reactive long-circulating lipid material capable of being connected with
a peptide fragment, and a cationic lipid material. The adhesion
receptor dipeptidase-1
binding peptide is specifically bound with adhesion
receptor dipeptidase generated by pulmonary vascular endothelial cells, passive targeting of lipidosome in the pulmonary vascular endothelial cells is achieved, and
pulmonary blood vessel normalization is promoted by inhibiting falling of
glycocalyx; meanwhile, the adhesion receptor dipeptidase-1
binding peptide can also reduce recruitment of neutrophil in the
lung and improve the microenvironment before
lung tumor
metastasis. The tumor
metastasis to the
lung can be reduced, and certain clinical application prospects are achieved in the aspect of treatment of lung
inflammation, vasculopathy and the like.